Pneumococcal Immunisation clinical trials

Explore recruiting pneumococcal immunisation clinical trials.

Recruiting pneumococcal immunisation studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pneumococcal Immunisation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group study to investigate the safety and immunogenicity of catch-up vaccination regimens of a 21-valent pneumococcal conjugate vaccine in healthy infants, toddlers, children, and adolescents

Estonia, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group, 2-arm study to investigate the safety and immunogenicity of a 21-valent pneumococcal conjugate vaccine in healthy infants and toddlers

Italy, Poland, Finland, Netherlands, Greece, Belgium +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pneumococcal Immunisation trials by city

Pneumococcal Immunisation clinical trials

Recruiting pneumococcal immunisation studies right now

Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV

Serum Collection Study for Assay Development

Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults

Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs

Clinical Trial Assessing the Immunogenicity of an Anti-pneumococcal Vaccination Strategy (PCV13+PPV23 Versus PREVENAR20) in Adult Patients Treated for a Lymphoma

Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents

Also recruiting in Europe

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group study to investigate the safety and immunogenicity of catch-up vaccination regimens of a 21-valent pneumococcal conjugate vaccine in healthy infants, toddlers, children, and adolescents

A Phase 3, randomized, modified double-blind, active-controlled, parallel-group, 2-arm study to investigate the safety and immunogenicity of a 21-valent pneumococcal conjugate vaccine in healthy infants and toddlers

Pneumococcal Immunisation trials by city

Other conditions